D.E. Shaw & Co’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$831K Sell
504,950
-356,661
-41% -$587K ﹤0.01% 2317
2025
Q1
$1.57M Sell
861,611
-269,894
-24% -$491K ﹤0.01% 1975
2024
Q4
$4.2M Buy
1,131,505
+558,235
+97% +$2.07M ﹤0.01% 1398
2024
Q3
$1.83M Buy
573,270
+484,361
+545% +$1.55M ﹤0.01% 1840
2024
Q2
$730K Sell
88,909
-415,424
-82% -$3.41M ﹤0.01% 2309
2024
Q1
$7.31M Sell
504,333
-142,473
-22% -$2.06M 0.01% 1091
2023
Q4
$5.96M Sell
646,806
-56,137
-8% -$517K 0.01% 1133
2023
Q3
$11.6M Sell
702,943
-333,690
-32% -$5.51M 0.01% 767
2023
Q2
$6.55M Sell
1,036,633
-87,595
-8% -$554K 0.01% 1113
2023
Q1
$3.82M Sell
1,124,228
-151,255
-12% -$514K ﹤0.01% 1499
2022
Q4
$7.37M Buy
1,275,483
+1,060,670
+494% +$6.13M 0.01% 1195
2022
Q3
$2.02M Buy
214,813
+108,938
+103% +$1.02M ﹤0.01% 2107
2022
Q2
$2.36M Buy
105,875
+96,218
+996% +$2.15M ﹤0.01% 2151
2022
Q1
$531K Sell
9,657
-12,802
-57% -$704K ﹤0.01% 3183
2021
Q4
$1.48M Buy
22,459
+17,701
+372% +$1.17M ﹤0.01% 2539
2021
Q3
$399K Sell
4,758
-300
-6% -$25.2K ﹤0.01% 2938
2021
Q2
$642K Sell
5,058
-43,008
-89% -$5.46M ﹤0.01% 2766
2021
Q1
$5.27M Buy
48,066
+12,870
+37% +$1.41M 0.01% 1325
2020
Q4
$5.03M Sell
35,196
-46,421
-57% -$6.63M ﹤0.01% 1305
2020
Q3
$5.76M Buy
81,617
+29,646
+57% +$2.09M 0.01% 1126
2020
Q2
$3.64M Sell
51,971
-53,203
-51% -$3.72M ﹤0.01% 1332
2020
Q1
$3.68M Sell
105,174
-301,852
-74% -$10.6M 0.01% 1211
2019
Q4
$25.6M Buy
+407,026
New +$25.6M 0.03% 497